Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 29-Mar-24 7:08 PM View:  | Moatazedi David See Remarks Director | Evolus, Inc. (EOLS) | 27-Mar-24 | Private Sale | 6,236 | $13.86 | $86,431.00 | (< 1%) 695.85K to 689.61K | |
| 21-Mar-24 6:09 PM View: | Beaver Sandra Chief Financial Officer | Evolus, Inc. (EOLS) | 19-Mar-24 | Private Sale | 5,672 | $13.92 | $78,978.10 | (4%) 159.87K to 154.2K | |
| 21-Mar-24 6:08 PM View: | Moatazedi David See Remarks Director | Evolus, Inc. (EOLS) | 19-Mar-24 | Private Sale | 96,566 | $13.92 | $1,344,600.00 | (12%) 792.42K to 695.85K | |
| 21-Mar-24 6:09 PM View: | Avelar Rui See Remarks | Evolus, Inc. (EOLS) | 19-Mar-24 | Private Sale | 27,603 | $13.92 | $384,350.00 | (7%) 399.89K to 372.29K | |
| 23-Feb-24 8:27 PM View: | Beaver Sandra Chief Financial Officer | Evolus, Inc. (EOLS) | 22-Feb-24 | Sale (Planned) | 1,821 | $13.08 | $23,820.90 | (1%) 161.69K to 159.87K | |
| 23-Feb-24 8:27 PM View: | Moatazedi David See Remarks Director | Evolus, Inc. (EOLS) | 22-Feb-24 | Sale (Planned) | 7,706 | $13.08 | $100,804.00 | (< 1%) 800.12K to 792.42K | |
| 23-Feb-24 8:27 PM View: | Avelar Rui See Remarks | Evolus, Inc. (EOLS) | 22-Feb-24 | Sale (Planned) | 1,821 | $13.08 | $23,820.90 | (< 1%) 401.71K to 399.89K | |
| 23-Feb-24 8:27 PM View: | Avelar Rui See Remarks | Evolus, Inc. (EOLS) | 21-Feb-24 | Grant | 13,115 | -- | -- | 3% 388.6K to 401.71K | |
| 23-Feb-24 8:27 PM View: | Beaver Sandra Chief Financial Officer | Evolus, Inc. (EOLS) | 21-Feb-24 | Grant | 13,115 | -- | -- | 9% 148.58K to 161.69K | |
| 23-Feb-24 8:27 PM View: | Moatazedi David See Remarks Director | Evolus, Inc. (EOLS) | 21-Feb-24 | Grant | 61,202 | -- | -- | 8% 738.92K to 800.12K | |
| 09-Feb-24 6:36 PM View: | Yamagishi-Dressler Tomoko Chief Marketing Officer | Evolus, Inc. (EOLS) | 07-Feb-24 | Grant | 24,648 | -- | -- | 100% 0 to 24.65K | |
| 09-Feb-24 6:37 PM View: | Hayman Robert Director | Evolus, Inc. (EOLS) | 07-Feb-24 | Grant | 6,464 | -- | -- | 11% 58.76K to 65.22K | |
| 09-Feb-24 6:37 PM View: | Stewart Brady Director | Evolus, Inc. (EOLS) | 07-Feb-24 | Grant | 6,464 | -- | -- | 14% 44.8K to 51.27K | |
| 09-Feb-24 6:36 PM View: | Beaver Sandra Chief Financial Officer | Evolus, Inc. (EOLS) | 07-Feb-24 | Grant | 35,211 | -- | -- | 31% 113.37K to 148.58K | |
| 09-Feb-24 6:38 PM View: | Blank Simone Director | Evolus, Inc. (EOLS) | 07-Feb-24 | Grant | 6,464 | -- | -- | 1% 546.07K to 552.53K | |
| 09-Feb-24 6:35 PM View: | Moatazedi David See Remarks Director | Evolus, Inc. (EOLS) | 07-Feb-24 | Grant | 134,976 | -- | -- | 22% 603.94K to 738.92K | |
| 09-Feb-24 6:37 PM View: | Gill David N Director | Evolus, Inc. (EOLS) | 07-Feb-24 | Grant | 6,464 | -- | -- | 17% 37.86K to 44.33K | |
| 09-Feb-24 6:37 PM View: | Parschauer Karah Herdman Director | Evolus, Inc. (EOLS) | 07-Feb-24 | Grant | 6,464 | -- | -- | 21% 31.24K to 37.71K | |
| 09-Feb-24 6:37 PM View: | Malik Vikram Director | Evolus, Inc. (EOLS) | 07-Feb-24 | Grant | 6,464 | -- | -- | 2% 275.55K to 282.01K | |
| 09-Feb-24 6:36 PM View: | Avelar Rui See Remarks | Evolus, Inc. (EOLS) | 07-Feb-24 | Grant | 35,211 | -- | -- | 10% 353.39K to 388.6K | |
| 02-Feb-24 4:57 PM View: | Parschauer Karah Herdman Director | Evolus, Inc. (EOLS) | 30-Jan-24 | Private Sale | 11,931 | $13.14 | $156,733.00 | (28%) 43.17K to 31.24K | |
| 08-Dec-23 6:15 PM View: | Moatazedi David See Remarks Director | Evolus, Inc. (EOLS) | 08-Dec-23 | Sale | 31,300 | $9.73 | $304,505.00 | (5%) 635.24K to 603.94K | |
| 08-Dec-23 6:15 PM View: | Moatazedi David See Remarks Director | Evolus, Inc. (EOLS) | 06-Dec-23 | Private Sale | 51,348 | $10.09 | $517,891.00 | (7%) 686.59K to 635.24K | |
| 18-Oct-23 4:21 PM View: | Medytox Inc. | Evolus, Inc. (EOLS) | 16-Oct-23 | Private Sale | 1,690,660 | $7.50 | $12,680,000.00 | (33%) 5.07M to 3.38M | |
| 08-Sep-23 8:54 PM View: | Beaver Sandra Chief Financial Officer | Evolus, Inc. (EOLS) | 06-Sep-23 | Private Sale (Planned) | 3,178 | $9.70 | $30,826.60 | (3%) 116.55K to 113.37K | |
| 23-Aug-23 8:07 PM View: | Yamagishi-Dressler Tomoko Chief Marketing Officer | Evolus, Inc. (EOLS) | 21-Aug-23 | Grant | 63,358 | -- | -- | 100% 0 to 63.36K | |
| 16-Aug-23 8:25 PM View: | Moatazedi David See Remarks Director | Evolus, Inc. (EOLS) | 16-Aug-23 | Sale (Planned) | 14,778 | $10.27 | $151,770.00 | (2%) 701.37K to 686.59K | |
| 16-Aug-23 8:25 PM View: | Avelar Rui See Remarks | Evolus, Inc. (EOLS) | 16-Aug-23 | Sale (Planned) | 2,211 | $10.27 | $22,707.00 | (< 1%) 355.6K to 353.39K | |
| 16-Aug-23 8:25 PM View: | Beaver Sandra Chief Financial Officer | Evolus, Inc. (EOLS) | 16-Aug-23 | Sale (Planned) | 2,211 | $10.27 | $22,707.00 | (2%) 118.76K to 116.55K | |
| 15-Aug-23 4:34 PM View: | Malik Vikram Director | Evolus, Inc. (EOLS) | 15-Aug-23 | Purchase | 174,967 | $7.41 | $1,296,510.00 | 174% 100.58K to 275.55K | |
| 16-Aug-23 8:25 PM View: | Moatazedi David See Remarks Director | Evolus, Inc. (EOLS) | 14-Aug-23 | Grant | 91,803 | -- | -- | 15% 609.57K to 701.37K | |
| 16-Aug-23 8:25 PM View: | Avelar Rui See Remarks | Evolus, Inc. (EOLS) | 14-Aug-23 | Grant | 19,672 | -- | -- | 6% 335.93K to 355.6K | |
| 16-Aug-23 8:25 PM View: | Beaver Sandra Chief Financial Officer | Evolus, Inc. (EOLS) | 14-Aug-23 | Grant | 19,672 | -- | -- | 20% 99.08K to 118.76K | |
| 15-Aug-23 4:32 PM View: | Blank Simone Director | Evolus, Inc. (EOLS) | 11-Aug-23 | Acquisition (other) | 115,206 | -- | -- | 27% 430.86K to 546.07K | |
| 15-Aug-23 4:34 PM View: | Malik Vikram Director | Evolus, Inc. (EOLS) | 11-Aug-23 | Acquisition (other) | 22,998 | -- | -- | 30% 77.58K to 100.58K | |
| 15-Aug-23 4:32 PM View: | Hayman Robert Director | Evolus, Inc. (EOLS) | 11-Aug-23 | Acquisition (other) | 218 | -- | -- | < 1% 58.17K to 58.39K | |
| 15-Aug-23 4:32 PM View: | Blank Simone Director | Evolus, Inc. (EOLS) | 11-Aug-23 | Acquisition (other) | 109 | -- | -- | < 1% 430.75K to 430.86K | |
| 15-Aug-23 4:32 PM View: | Hayman Robert Director | Evolus, Inc. (EOLS) | 11-Aug-23 | Acquisition (other) | 366 | -- | -- | < 1% 58.39K to 58.76K | |
| 29-Mar-23 5:11 PM View: | Moatazedi David See Remarks Director | Evolus, Inc. (EOLS) | 27-Mar-23 | Private Sale (Planned) | 6,110 | $8.47 | $51,751.70 | (< 1%) 615.68K to 609.57K | |
| 16-Mar-23 10:00 PM View: | Moatazedi David See Remarks Director | Evolus, Inc. (EOLS) | 14-Mar-23 | Private Sale (Planned) | 64,211 | $8.47 | $543,796.00 | (9%) 679.89K to 615.68K | |
| 16-Mar-23 10:00 PM View: | Avelar Rui See Remarks | Evolus, Inc. (EOLS) | 14-Mar-23 | Private Sale (Planned) | 14,906 | $8.47 | $126,237.00 | (4%) 350.83K to 335.93K | |
| 22-Feb-23 4:01 PM View: | Alphaeon 1 LLC 10% Owner | Evolus, Inc. (EOLS) | 17-Feb-23 | Private Sale | 1,850,000 | $8.40 | $15,540,000.00 | (31%) 6.06M to 4.21M | |
| 08-Feb-23 8:10 PM View: | Medytox Inc. 10% Owner | Evolus, Inc. (EOLS) | 07-Feb-23 | Private Sale | 2,187,510 | $8.50 | $18,593,800.00 | (30%) 7.26M to 5.07M | |
| 31-Jan-23 8:41 PM View: | Blank Simone Director | Evolus, Inc. (EOLS) | 27-Jan-23 | Grant | 8,293 | -- | -- | 2% 422.46K to 430.75K | |
| 31-Jan-23 8:42 PM View: | Hayman Robert Director | Evolus, Inc. (EOLS) | 27-Jan-23 | Grant | 8,293 | -- | -- | 17% 49.88K to 58.17K | |
| 31-Jan-23 8:41 PM View: | Parschauer Karah Herdman Director | Evolus, Inc. (EOLS) | 27-Jan-23 | Grant | 8,293 | -- | -- | 24% 34.88K to 43.17K | |
| 31-Jan-23 8:41 PM View: | Gill David N Director | Evolus, Inc. (EOLS) | 27-Jan-23 | Grant | 8,293 | -- | -- | 28% 29.57K to 37.86K | |
| 31-Jan-23 8:42 PM View: | Malik Vikram Director | Evolus, Inc. (EOLS) | 27-Jan-23 | Grant | 8,293 | -- | -- | 12% 69.29K to 77.58K | |
| 31-Jan-23 8:40 PM View: | Farrell Peter C Director | Evolus, Inc. (EOLS) | 27-Jan-23 | Grant | 8,293 | -- | -- | 18% 44.88K to 53.17K | |
| 31-Jan-23 8:42 PM View: | Stewart Brady Director | Evolus, Inc. (EOLS) | 27-Jan-23 | Grant | 8,293 | -- | -- | 23% 36.51K to 44.8K |
